Related Experiment Video
Updated: Mar 3, 2026
Author Spotlight: The Production of Recombinant Proteins
Published on: June 30, 2023
[Cloning, purification and biological activity of human vascular endothelial growth factor fragment in E. coli]
Xianmao Li1, Weisen Zeng, Yali Zhang
1Instititue of Gastroenterology, Nanfang Hospital, First Military Medical University of PLA, Guangzhou 510515, China.
Objective:
To observe the effect of human vascular endothelial growth factor (VEGF) fragment (3 approximately 4 exon) in E. coli on anti-angiogenesis.
Methods:
Through RT-PCR amplification, endonuclease cut and DNA sequence analysis identification, hVEGF fragment cDNA was inserted into E. coli expression vector pTrcHis2A. The prokaryotic expression plasmid pTrcHis2A/VEGF(3 approximately 4) was constructed and transformed into TOP10F.
Results:
After 8hr isopropy-beta-D-thiogalactoside (IPTG) induction, VEGF fragment was expressed in 15% of total proteins through sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The expressed protein was highly antigenic and specific. The VEGF fragment was further purified by affinity, which could inhibit HUVEC proliferation and neovascularization of the chick chorioallantoic membrane.
Conclusion:
VEGF fragment is anti-angiogenetic, which may potentially be used in oncologico-biological targeting therapy.
